Clin2
NCT07560735Possibly a fitNot yet recruiting

Lifitegrast eye drops for dry eye disease evaluation

Dry Eye

Part of Eyes & vision clinical trials.

This study tests whether lifitegrast eye drops (a medication that reduces eye inflammation) help people with moderate to severe dry eye disease. Researchers will use a special microscope to examine your eye surface before and after treatment.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
30 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have had dry eye symptoms for at least 6 months
  • Your eyes show moderate corneal damage (staining score ≥2) on examination
  • Your tear production is low but not completely absent (Schirmer test 1–10mm)
  • You are at least 18 years old with vision of 20/100 or better in both eyes
  • You are willing to stop wearing contact lenses and not use certain eye drops or steroids during the study
  • You have not previously tried lifitegrast or had eye surgery in the past year

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07625124Not yet recruiting· Phase 2
Testing a new eye drop for dry eye disease

This study tests whether RCI001, a new eye drop treatment, can help people with dry eye disease. If you've had dry eye symptoms for at least 6 months and are interested in trying a new treatment, this trial may be for you.

NCT07510620Recruiting· Phase 4
Dry eye treatment for contact lens wearers

This trial tests a treatment for dry eye in people who wear contact lenses. It may help if you've tried other dry eye treatments before.

Kingston, Pennsylvania
NCT07245017Recruiting· Early Phase 1
Testing JN002 drops for dry eye disease

This trial tests whether a new eye drop, JN002, can help people with dry eye disease. It checks if the drops improve symptoms and eye health over time.

Shanghai
NCT07790211Recruiting· Phase 4
Eye drop for tear film stability

This study tests an eye drop to help stabilize the natural tear film on the surface of the eye. It may help people who have normal tear production but could benefit from better tear film stability.

Sioux Falls, South Dakota
NCT06379685Not yet recruiting· Phase 1
Testing new eye drops for safety and comfort

This study tests a new eye drop (PRO-190) against a common artificial tear (Systane Ultra) to see how safe and comfortable it is. Healthy volunteers will use the drops and be monitored for any side effects or changes in their eyes.

NCT06879782Recruiting· Phase 3
Eye drops for dry eye disease: a phase 3 study

This study tests an eye drop called lifitegrast for people with dry eye disease. It looks at whether the drops can improve eye comfort, reduce dryness, and help eye surface health. You may be able to join if you have had dry eye symptoms and used artificial tears in the past month.

Beijing, Beijing Municipality

Hear when a new Dry Eye trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.